Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia


Submitted: 17 July 2015
Accepted: 19 July 2016
Published: 28 November 2016
Abstract Views: 2174
PDF: 1060
HTML: 655
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Ilaria Riccio Department of Medical and Surgical Specialties and Dentistry, Second University of Naples, Naples, Italy.
  • Elvira Pota Pediatric Oncology Service, Pediatric Department, Second University of Naples, Naples, Italy.
  • Marco Marcarelli Department of Medical and Surgical Specialties and Dentistry, Second University of Naples, Naples, Italy.
  • Maria Carmen Affinita Pediatric Oncology Service, Pediatric Department, Second University of Naples, Naples, Italy.
  • Daniela Di Pinto Pediatric Oncology Service, Pediatric Department, Second University of Naples, Naples, Italy.
  • Cristiana Indolfi Pediatric Oncology Service, Pediatric Department, Second University of Naples, Naples, Italy.
  • Nicola Del Regno Department of Medical and Surgical Specialties and Dentistry, Second University of Naples, Naples, Italy.
  • Marco Esposito Department of Medical and Surgical Specialties and Dentistry, Second University of Naples, Naples, Italy.
Osteonecrosis is a significant adverse effect of treatment administered to children suffering from acute lymphoblastic leukemia (ALL) that may have a negative effect on the quality of life. The purpose of this study is to evaluate the rate of secondary vascular osteonecrosis (ON) in a population of pediatric patients with ALL treated with corticosteroids and cytostatic agents. A retrospective analysis of prospectively collected data of the medical records of 328 patients with ALL identified 4 cases with ON, corresponding to 1.2% of all cases observed. Of the 4 patients identified in our study 3 were girls and 1 was a boy, aged from 10 to 16 years old (average age at diagnosis, 12 years). Median time between the diagnosis of ALL and ON was 12.5 months (range, 12 to 36 months). Regarding the lesion size of ON, in all cases the femoral head (monolateral in 1 case and bilateral in 3 cases) was involved and was associated with the scapula-humeral joint in one case. ON of the weight-bearing joints has been identified as a severe complication in children with leukemia that may be associated with the development of articular surface collapse, subsequent debilitating arthritis, sometimes needing arthroplasty. For this reason it is very important to implement prevention strategies, especially in adolescent girls treated with steroids and chemotherapy. An early diagnosis of ON and careful orthopedic follow-up are necessary in order to avoid bone deformations related to the late start or the wrong therapy.

Riccio, I., Pota, E., Marcarelli, M., Affinita, M. C., Di Pinto, D., Indolfi, C., Del Regno, N., & Esposito, M. (2016). Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia. La Pediatria Medica E Chirurgica, 38(3). https://doi.org/10.4081/pmc.2016.118

Downloads

Download data is not yet available.

Citations